rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Medline Inc.

MDLN · Nasdaq

Health CareMedical DevicesNot moving yet

MDLN stood above a rising 150-day average in 0 of the last 9 weekly readings. It is 6.7% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 9
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$515.1M
Insider sales, 12 months
$26.2B
Officials’ trades on record
0
Institutions holding
382 (+86)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 9 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$14.6B$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months4
Sale orders, 12 months39
Buyers · sellers4 · 22
WhoDidSharesTraded
Gic Private Ltd10% ownersold7,816,987at $35.158 Oct 2026filed 13 Oct 2026
Gic Private Ltd10% ownersold2,088,987at $35.056 Oct 2026filed 6 Oct 2026
Gic Private Ltd10% ownersold7,183,013at $35.056 Oct 2026filed 6 Oct 2026
Gic Private Ltd10% ownersold1,688,690at $35.785 Oct 2026filed 6 Oct 2026
Gic Private Ltd10% ownersold2,570,999at $35.352 Oct 2026filed 6 Oct 2026
Gic Private Ltd10% ownersold7,146,941at $34.332 Oct 2026filed 6 Oct 2026
Gic Private Ltd10% ownersold100,000at $35.8014 Aug 2026filed 17 Aug 2026
Gic Private Ltd10% ownersold1,500,000at $35.8013 Aug 2026filed 17 Aug 2026
Gic Private Ltd10% ownersold590,284at $35.587 Aug 2026filed 11 Aug 2026
Gic Private Ltd10% ownersold271,994at $35.336 Aug 2026filed 7 Aug 2026
Gic Private Ltd10% ownersold1,710,907at $35.465 Aug 2026filed 7 Aug 2026
Gic Private Ltd10% ownersold265,711at $36.485 Aug 2026filed 7 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders382+86 on the quarter
New · exited165 · 78
Reported value$29.0B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Carlyle Group Inc.unchanged · filed 7 Aug 2026187,083,713$7.4B00.0%
H&F Corporate Investors X, Ltd.reduced · filed 12 Aug 202670,874,326$2.8B-15,599,171−18.0%
FMR LLCadded · filed 13 Aug 202646,963,203$1.9B+10,407,002+28.5%
Capital Research Global Investorsadded · filed 12 Aug 202639,963,790$1.6B+16,802,120+72.5%
Invesco Ltd.added · filed 14 Aug 202638,346,937$1.5B+17,383,322+82.9%
BlackRock, Inc.added · filed 7 Aug 202626,393,587$1.0B+9,469,927+56.0%
MORGAN STANLEYadded · filed 13 Aug 202621,605,662$852.1M+5,902,759+37.6%
LONE PINE CAPITAL LLCadded · filed 14 Aug 202620,968,367$827.0M+9,179,211+77.9%
MASSACHUSETTS FINANCIAL SERVICES COadded · filed 3 Aug 202619,888,806$787.1M+8,319,490+71.9%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202617,816,057$702.7M+3,086,376+21.0%
31 Dec 2025 – 30 Jun 2026
201288375Dec 25Mar 26Jun 26

News

No headline names it lately.

Everyone who traded it

GIC Private Ltd Company insider10% owner · last 8 Oct 20260 · 9
James M. Boyle Company insiderChief Executive Officer · last 19 Aug 20260 · 0
Stephen L. Miller Company insiderChief Operating Officer · last 19 Aug 20260 · 0
Hux Investment Pte. Ltd. Company insider10% owner · last 14 Aug 20260 · 4
Mozart Holdco, Inc. Company insider10% owner · last 6 Aug 20260 · 0
Douglas P. Golwas Company insiderChief Commercial Officer · last 16 Jun 20260 · 1
Alexander M. Liberman Company insiderChief Legal Officer · last 15 Jun 20260 · 0
Amanda H. Laabs Company insiderChief Product Officer · last 15 Jun 20260 · 0
Christopher P. Shryock Company insiderChief Human Resources Officer · last 15 Jun 20260 · 0
Michael B. Drazin Company insiderChief Financial Officer · last 15 Jun 20260 · 0
William J. Abrams Company insiderOfficer · last 15 Jun 20260 · 0
Richard A. Galanti Company insiderDirector · last 11 Jun 20260 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202526.4%
Operating profit marginFY 2025 · to 31 Dec 20257.8%
Free cash flow marginFY 2025 · to 31 Dec 20254.6%
Return on capital employedFY 2025 · to 31 Dec 20256.1%
Debt to equityFY 2025 · to 31 Dec 20251.17×
Research spendFY 2025 · to 31 Dec 20250.3%
Revenue growthFY 2025 · to 31 Dec 20249.8%
Cash and equivalentsFY 2025 · to 31 Dec 2025$1.9B
Free cash flowFY 2025 · to 31 Dec 2025$1.3B

Analyst forecasts

No analyst forecasts yet.